Operating within the personalized healthcare and preventive medicine sector, Haoma provides genomic screening and precision health services tailored to each client’s unique genetic profile. Its offerings include metabolic profiling, personalized nutrition programs, custom dietary recommendations, nutrient optimization plans, and predictive wellness analytics designed to support proactive health management.

Haoma’s business model centers on delivering comprehensive genomic and AI-driven health services to health-conscious individuals seeking data-informed lifestyle and medical insights. Revenue is generated through genetic testing, clinical genomic screening, ongoing health monitoring services, and customized wellness programs.

A core aspect of the company’s approach is pharmacogenomics — the integration of genomics and pharmacology to better understand how individuals respond to medications, nutrients, and lifestyle factors. By analyzing genetic predispositions, Haoma aims to support early disease risk identification, personalized preventive interventions, and more targeted treatment planning.

The company also leverages artificial intelligence and advanced analytics to interpret genetic data and provide actionable recommendations that help clients optimize nutrition, fitness, recovery, and overall wellness. Through its precision-health framework, Haoma positions itself as a provider of next-generation preventive healthcare solutions focused on improving patient outcomes through personalized medicine and predictive health intelligence.